Summary (IA Generated)
U.S. femtech startup CurieMD
is offering menopause diagnosis and treatment prescription via a telehealth platform — beginning in California, where it launched late last year. Founder Dr Leslie Meserve says the goal is to widen access to treatment and support services for mid-life women, spying a business opportunity in offering an auxiliary digital service targeting an area of women’s health which she says is often overlooked within standard health service provision and suffers from a lack of trained physicians. […] What they didn’t say was that in the estrogen-only arm of the trial there was actually a lower incidence of breast cancer. So that was never stated anywhere. The other thing they failed to state was that the slight increased risk was not statistically significant… […] There are certain things that need to have an in person visit. But the medical community is starting to understand and adapt and trust telehealth — but I think the more data that we have the more we’re going to be able to convince them that this is a nice adjunct to in person visits.” Patients are more accepting of than physicians are. Physicians are very conservative and very slow to change and so I feel that one of our missions is to present the data to physicians and help them understand that this is not a substitute for good in-person care, it’s just an addition,” she adds. […] In an FAQ
on its website startup claims its consultation fees “are lower than that of most copays and our medication pricing is competitive with that of most pharmacies”).